Rocket Pharmaceuticals, Inc. (RCKT)
2.445
-0.10
(-3.74%)
USD |
NASDAQ |
Oct 30, 16:00
2.445
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Cash and Short Term Investments (Annual) : 188.93M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 188.93M |
| December 31, 2024 | 372.34M |
| December 31, 2023 | 373.18M |
| December 31, 2022 | 356.39M |
| December 31, 2021 | 388.74M |
| December 31, 2020 | 482.72M |
| December 31, 2019 | 304.12M |
| Date | Value |
|---|---|
| December 31, 2018 | 205.73M |
| December 31, 2017 | 18.14M |
| December 31, 2016 | 126.47M |
| December 31, 2015 | 111.28M |
| December 31, 2014 | 3.618M |
| December 31, 2013 | 12.79M |
| December 31, 2012 | 1.372M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 939.65M |
| Intellia Therapeutics, Inc. | 449.88M |
| Beam Therapeutics, Inc. | 1.245B |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |